The FTL Sarcoma Fund, in partnership with the T.J. Martell Foundation, recently presented a gift to the Vanderbilt-Ingram Cancer Center in support of sarcoma research in memory of Warner Music Nashville colleague Lindsay Walleman.

The next Bedside Matters, an hourlong, monthly rounds geared toward helping Vanderbilt University Medical Center health care providers deal with the social and emotional issues of caring for patients and families, will take place on Wednesday, April 16.

Autopsies have revealed that some individuals develop the cellular changes indicative of Alzheimer’s disease without ever showing clinical symptoms in their lifetime.

The extracellular matrix that surrounds cells plays a role in the development of insulin resistance.

New construction and the start of a new substantial academic venture capital fund were among the topics brought up by Chancellor Nicholas S. Zeppos during his address at Spring Faculty Assembly.

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.